You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Pregabalin monotherapy for epilepsy
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2012
|
| DOI | 10.1002/14651858.cd009429.pub2 |
| Pubmed ID | |
| Authors |
Qin Zhou, Jinou Zheng, Lu Yu, Xiaoyan Jia |
| Abstract |
Many people with epilepsy suffer from poorly controlled seizures, despite current antiepileptic treatments. Due to high rates of treatment resistance, there is interest in new pharmacological treatment options such as pregabalin. However, it remains unclear whether existing evidence of pregabalin is rigorous enough to support its monotherapy. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 13% |
| Unknown | 7 | 88% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 134 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| South Africa | 1 | <1% |
| Unknown | 131 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 17 | 13% |
| Student > Master | 16 | 12% |
| Student > Ph. D. Student | 14 | 10% |
| Student > Bachelor | 14 | 10% |
| Student > Postgraduate | 10 | 7% |
| Other | 24 | 18% |
| Unknown | 39 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 45 | 34% |
| Nursing and Health Professions | 13 | 10% |
| Psychology | 10 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Other | 14 | 10% |
| Unknown | 40 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 April 2024.
All research outputs
#3,686,151
of 25,744,802 outputs
Outputs from Cochrane database of systematic reviews
#6,358
of 13,136 outputs
Outputs of similar age
#26,550
of 193,748 outputs
Outputs of similar age from Cochrane database of systematic reviews
#114
of 240 outputs
Altmetric has tracked 25,744,802 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,136 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,748 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 240 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.